Keyphrases
CMV Vaccine
100%
Guinea pig CMV
100%
Guinea pig
100%
Tegument Protein
100%
Pregnancy Outcome
100%
P-p65
100%
Challenge Model
100%
Placental Infection
100%
Vaccination
80%
DNAemia
80%
Human CMV
60%
In Situ Hybridization
40%
Salivary Gland
40%
Pupal Mortality
40%
Virus
20%
Two-dose
20%
Placebo
20%
Natural Infection
20%
Recombinant
20%
Congenital Infection
20%
CMV Infection
20%
Immunization
20%
T Cell Immune Response
20%
Neurodevelopmental
20%
Intellectual Disability
20%
Vaccine Strategy
20%
Placenta
20%
Live Attenuated Vaccine
20%
Unvaccinated
20%
Second Trimester
20%
Sudden Sensorineural Hearing Loss (SSNHL)
20%
Targeted Deletion
20%
Antibody Response
20%
Congenital Disorders
20%
Pregnant Animals
20%
Outbred
20%
CMV Disease
20%
Hartley Guinea pig
20%
Protective Efficacy
20%
Attenuated Virus
20%
Second Pregnancy
20%
Infectious Focus
20%
Medicine and Dentistry
Infection
100%
Tegument
100%
Cytomegalovirus Infection
40%
Salivary Gland
40%
In Situ Hybridization
40%
T Cell
20%
Congenital Infection
20%
Immune Response
20%
Virus
20%
Placenta
20%
Neonatal Infant
20%
Sequela
20%
Enzyme Linked Immunosorbent Assay
20%
Sensorineural Hearing Loss
20%
Second Trimester Pregnancy
20%
Antibody Response
20%
Congenital Disorder
20%
Virus Attenuation
20%
Placebo
20%
Live Vaccine
20%
Immunology and Microbiology
Guinea Pig
100%
Infection
100%
Salivary Gland
28%
In Situ Hybridization
28%
Virus
14%
Attenuated Vaccine
14%
Placenta
14%
Immune Response
14%
ELISA
14%
Live Vaccine
14%
Antibody Response
14%
Second Trimester Pregnancy
14%
Hartley Guinea Pig
14%
Virus Attenuation
14%
T Cell
14%
Pharmacology, Toxicology and Pharmaceutical Science
Guinea Pig
100%
Infection
100%
Cytomegalovirus Infection
28%
Live Vaccine
14%
Enzyme-Linked Immunosorbent Assay
14%
Hartley Guinea Pig
14%
Placebo
14%
Congenital Infection
14%
Perception Deafness
14%
Congenital Disorder
14%